All these services are available via a service fee combined with a licence arrangement. In addition to our service offerings licences for specific applications of CIS display to proprietary systems are also available.

 

We offer our clients rapid screening, selection and maturation of peptides, proteins and antibodies with the aim of identifying candidates with superior binding to biological targets.

We use our technology to develop potential therapeutic candidates, validate targets and select biologics with enhanced biological activity, protease resistance or cell penetrating capabilities. We also undertake bespoke library design and selection optimisation of pre-selected, high quality peptides, protein scaffolds and antibody fragments.

 

 

All these services are available via a service and licence arrangement. In addition to our service offerings licences for specific applications of CIS display to proprietary systems are also available.

We are also actively seeking out-licensing opportunities for an antimicrobial peptide and an NGF antagonist as a result of our in-house discovery programme.

To find out more or arrange a meeting please contact us.